Financial Survey: Profusa (NASDAQ:PFSA) vs. TransEnterix (OTCMKTS:TRXDW)

Profusa (NASDAQ:PFSA) and TransEnterix (OTCMKTS:TRXDW) are both small-cap manufacturing companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.

Profitability

This table compares Profusa and TransEnterix’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Profusa	N/A	N/A	N/A
TransEnterix	-2,149.15%	-83.74%	-64.94%

Valuation and Earnings

This table compares Profusa and TransEnterix”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profusa	N/A	N/A	N/A	N/A	N/A
TransEnterix	$8.53 million	2.51	-$154.20 million	($4.22)	-0.04

Profusa has higher earnings, but lower revenue than TransEnterix.

Insider & Institutional Ownership

9.8% of Profusa shares are held by institutional investors. Comparatively, 8.2% of TransEnterix shares are held by institutional investors. 21.6% of Profusa shares are held by insiders. Comparatively, 3.1% of TransEnterix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Profusa has a beta of -0.14, suggesting that its share price is 114% less volatile than the S&P 500. Comparatively, TransEnterix has a beta of 2.56, suggesting that its share price is 156% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and price targets for Profusa and TransEnterix, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profusa	1	0	0	0	1.00
TransEnterix	0	0	0	0	0.00

Summary

Profusa beats TransEnterix on 6 of the 8 factors compared between the two stocks.

About Profusa

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.

About TransEnterix

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.